These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15952486)

  • 21. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.
    D'Anna R; Cannata ML; Marini H; Atteritano M; Cancellieri F; Corrado F; Triolo O; Rizzo P; Russo S; Gaudio A; Frisina N; Bitto A; Polito F; Minutoli L; Altavilla D; Adamo EB; Squadrito F
    Menopause; 2009; 16(2):301-6. PubMed ID: 19034051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of TCM acupuncture on hot flushes among menopausal women (ACUFLASH) study: a study protocol of an ongoing multi-centre randomised controlled clinical trial.
    Borud EK; Alraek T; White A; Fonnebo V; Grimsgaard S
    BMC Complement Altern Med; 2007 Feb; 7():6. PubMed ID: 17324253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors.
    Biglia N; Torta R; Roagna R; Maggiorotto F; Cacciari F; Ponzone R; Kubatzki F; Sismondi P
    Maturitas; 2005 Sep; 52(1):78-85. PubMed ID: 16143229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
    Evans ML; Pritts E; Vittinghoff E; McClish K; Morgan KS; Jaffe RB
    Obstet Gynecol; 2005 Jan; 105(1):161-6. PubMed ID: 15625158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study.
    Nedstrand E; Wijma K; Wyon Y; Hammar M
    Climacteric; 2005 Sep; 8(3):243-50. PubMed ID: 16390756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
    Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
    Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.
    Archer DF; Seidman L; Constantine GD; Pickar JH; Olivier S
    Am J Obstet Gynecol; 2009 Feb; 200(2):172.e1-10. PubMed ID: 19110224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hot flushes, bone mineral density, and fractures in older postmenopausal women.
    Huang A; Grady D; Blackwell T; Bauer D
    Obstet Gynecol; 2007 Apr; 109(4):841-7. PubMed ID: 17400844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
    Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
    Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
    Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
    Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New therapeutic approaches for hot flashes in women.
    Stearns V; Loprinzi CL
    J Support Oncol; 2003; 1(1):11-21; discussion 14-5, 19-21. PubMed ID: 15352639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
    Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
    J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptoms and treatment in cancer therapy-induced early menopause.
    Boekhout AH; Beijnen JH; Schellens JH
    Oncologist; 2006 Jun; 11(6):641-54. PubMed ID: 16794243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial.
    Grady D; Sawaya GF; Johnson KC; Koltun W; Hess R; Vittinghoff E; Kristof M; Tagliaferri M; Cohen I; Ensrud KE
    Menopause; 2009; 16(3):458-65. PubMed ID: 19182698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility and acceptability of restorative yoga for treatment of hot flushes: a pilot trial.
    Cohen BE; Kanaya AM; Macer JL; Shen H; Chang AA; Grady D
    Maturitas; 2007 Feb; 56(2):198-204. PubMed ID: 16979311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
    Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
    Pockaj BA; Gallagher JG; Loprinzi CL; Stella PJ; Barton DL; Sloan JA; Lavasseur BI; Rao RM; Fitch TR; Rowland KM; Novotny PJ; Flynn PJ; Richelson E; Fauq AH
    J Clin Oncol; 2006 Jun; 24(18):2836-41. PubMed ID: 16782922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A survey among breast cancer survivors: treatment of the climacteric after breast cancer.
    Antoine C; Vandromme J; Fastrez M; Carly B; Liebens F; Rozenberg S
    Climacteric; 2008 Aug; 11(4):322-8. PubMed ID: 18645698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
    Bordeleau L; Pritchard KI; Loprinzi CL; Ennis M; Jugovic O; Warr D; Haq R; Goodwin PJ
    J Clin Oncol; 2010 Dec; 28(35):5147-52. PubMed ID: 21060031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.